Literature DB >> 3663701

Nephrotoxicity and its prevention by vitamin E in ferric nitrilotriacetate-promoted lipid peroxidation.

S Okada1, S Hamazaki, Y Ebina, J L Li, O Midorikawa.   

Abstract

Iron and aluminum complexes of nitrilotriacetic acid cause severe nephrotoxicity in Wistar rats. In addition, a high incidence of renal cell carcinoma is seen in ferric nitrilotriacetate-treated animals. The present study was performed to see if lipid peroxidation is involved in ferric nitrilotriacetate toxicity. Ferric nitrilotriacetate had more bleomycin-detectable 'free' iron than any ferric salt, while iron complexed with desferrioxamine or ferric chondroitin sulfate had none. The toxicity of ferric nitrilotriacetate in vivo was more pronounced in vitamin E-deficient rats. A thiobarbituric acid-reactive substance was present in the kidneys of vitamin E-deficient rats in amounts markedly elevated compared to vitamin E-sufficient, or vitamin E-supplemented rats. Non-complexed nitrilotriacetate or aluminum nitrilotriacetate did not produce any thiobarbituric acid-reactive substance in vitamin E-sufficient rats died by the 58th day of administration. We suggest that the iron-stimulated production of free radicals leading to lipid peroxidation is the major cause of ferric nitrilotriacetate-mediated renal toxicity. Vitamin E, a known scavenger of free radicals, is effective in protecting against this iron-induced toxicity.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3663701     DOI: 10.1016/0005-2760(87)90241-4

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  11 in total

1.  Premenopausal plasma ferritin levels, HFE polymorphisms, and risk of breast cancer in the nurses' health study II.

Authors:  Rebecca E Graff; Eunyoung Cho; Sara Lindström; Peter Kraft; Walter C Willett; A Heather Eliassen
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-01-17       Impact factor: 4.254

2.  BRCA1 haploinsufficiency promotes chromosomal amplification under Fenton reaction-based carcinogenesis through ferroptosis-resistance.

Authors:  Yingyi Kong; Shinya Akatsuka; Yashiro Motooka; Hao Zheng; Zhen Cheng; Yukihiro Shiraki; Tomoji Mashimo; Tatsuhiko Imaoka; Shinya Toyokuni
Journal:  Redox Biol       Date:  2022-05-28       Impact factor: 10.787

3.  Renal cysts and associated renal tumours in male ddY mice injected with ferric nitrilotriacetate.

Authors:  A Kondo; J Deguchi; S Okada
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

4.  Cirrhosis of the liver induced by cupric nitrilotriacetate in Wistar rats. An experimental model of copper toxicosis.

Authors:  S Toyokuni; S Okada; S Hamazaki; M Fujioka; J L Li; O Midorikawa
Journal:  Am J Pathol       Date:  1989-06       Impact factor: 4.307

5.  Formation of 4-hydroxy-2-nonenal-modified proteins in the renal proximal tubules of rats treated with a renal carcinogen, ferric nitrilotriacetate.

Authors:  S Toyokuni; K Uchida; K Okamoto; Y Hattori-Nakakuki; H Hiai; E R Stadtman
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-29       Impact factor: 11.205

6.  Rapid in vitro transformation system for liver epithelial cells by iron chelate, Fe-NTA.

Authors:  M Yamada; M Awai; T Okigaki
Journal:  Cytotechnology       Date:  1990-03       Impact factor: 2.058

7.  Increase in the 8-hydroxyguanine repair activity in the rat kidney after the administration of a renal carcinogen, ferric nitrilotriacetate.

Authors:  R Yamaguchi; T Hirano; S Asami; A Sugita; H Kasai
Journal:  Environ Health Perspect       Date:  1996-05       Impact factor: 9.031

8.  Protection by alpha G-rutin, a water-soluble antioxidant flavonoid, against renal damage in mice treated with ferric nitrilotriacetate.

Authors:  K Shimoi; B Shen; S Toyokuni; R Mochizuki; M Furugori; N Kinae
Journal:  Jpn J Cancer Res       Date:  1997-05

9.  Sex hormone-dependent renal cell carcinogenesis induced by ferric nitrilotriacetate in Wistar rats.

Authors:  J Deguchi; M Miyamoto; S Okada
Journal:  Jpn J Cancer Res       Date:  1995-11

Review 10.  The Role of Ferric Nitrilotriacetate in Renal Carcinogenesis and Cell Death: From Animal Models to Clinical Implications.

Authors:  Yasumasa Okazaki
Journal:  Cancers (Basel)       Date:  2022-03-15       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.